Impact of FLT3 ITD/NPM1 mutation status in adult patients with acute myelocytic leukemia autografted in first remission

• Norbert-Claude Gorin,
• Myriam Labopin,
• Giovanna Meloni,
• Arnaud Pigneux,
• Jordi Esteve,
• Mohty Mohamad

Affiliations

Norbert-Claude Gorin

Hôpital Saint Antoine, Department of Hematology, Paris, France;Centre International Greffes and Acute Leukemia Working Party (ALWP), EBMT Paris Office, Hopital Saint-Antoine APHP, and UMR-S 893, Equipe 14, Université Pierre et Marie Curie UPMC Paris 6, France

Myriam Labopin

Centre International Greffes and Acute Leukemia Working Party (ALWP), EBMT Paris Office, Hopital Saint-Antoine APHP, and UMR-S 893, Equipe 14, Université Pierre et Marie Curie UPMC Paris 6, France

Giovanna Meloni

University La Sapienza, Dipartimento di Biotecnologie Cellulari e Ematologia, Rome, Italy

Arnaud Pigneux

CHU Bordeaux Hôpital Haut-Leveque, Pessac, France

Jordi Esteve

Department of Hematology, Hospital Clinic, IDIBAPS, Barcelona, Spain

Mohty Mohamad

Centre Hospitalier et Universitaire, Hematologie Clinique, Nantes, France